Jodie Gahn-Stahley
Family Medicine · Castle Rock, CONPI 1508012865
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 127 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 12.5% — the pattern of someone who eats at a lot of different presentations. Among family medicine clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 127 payments — averaging $21.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$337
- Edwards Lifesciences$270
- Novo Nordisk$224
- Bayer$211
- AstraZeneca$174
- Otsuka America Pharmaceutical, Inc.$113
- plus $1K from 28 others
What the payments were for
- Food & beverage$2,696100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 17 | $337 |
| Edwards Lifesciences | 6 | $270 |
| Novo Nordisk | 12 | $224 |
| Bayer | 11 | $211 |
| AstraZeneca | 8 | $174 |
| Otsuka America Pharmaceutical, Inc. | 6 | $113 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $107 |
| Amgen | 5 | $94 |
| Neurocrine Biosciences, Inc. | 4 | $78 |
| Corium, LLC | 4 | $76 |
| Alkermes, Inc. | 3 | $71 |
| Astellas Pharma US Inc | 2 | $66 |
| Pfizer | 3 | $57 |
| Lundbeck LLC | 3 | $55 |
| GSK | 2 | $55 |
| Axsome Therapeutics, Inc. | 2 | $55 |
| Johnson & Johnson | 2 | $52 |
| Kowa Pharmaceuticals America, Inc. | 2 | $51 |
| Exact Sciences | 2 | $50 |
| Idorsia Pharmaceuticals US Inc | 3 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $50 |
| Merck | 3 | $48 |
| Seqirus USA Inc | 2 | $45 |
| Lilly USA, LLC | 3 | $42 |
| Nevro Corp. | 2 | $39 |
| Paratek Pharmaceuticals, Inc. | 2 | $38 |
| Phathom Pharmaceuticals, Inc. | 2 | $34 |
| Aimmune Therapeutics, Inc. | 2 | $32 |
| Amneal Pharmaceuticals LLC | 1 | $27 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Dexcom, Inc. | 1 | $20 |
| Boston Scientific | 1 | $18 |
| Exeltis, USA Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,696 in reported general payments places this provider in the 90th percentile of 2,079 family medicine providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $11,910 |
| SymbicortBudesonide/Formoterol Fumarate | 13 | $2,923 |
| ValacyclovirValacyclovir Hcl | 11 | $1,701 |
| SynthroidLevothyroxine Sodium | 20 | $823 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $734 |
| Gabapentin | 36 | $691 |
| Levothyroxine Sodium | 71 | $667 |
| Liothyronine Sodium | 24 | $553 |
| Metoprolol Succinate | 22 | $344 |
| Duloxetine Hcl | 22 | $337 |
| Bupropion XlBupropion Hcl | 11 | $312 |
| Potassium Chloride | 21 | $311 |
| Trazodone Hcl | 20 | $289 |
| Rosuvastatin Calcium | 31 | $255 |
| Ezetimibe | 29 | $239 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $57 | $11,91012 claims |
| AstraZenecaSymbicort | $174 | $2,92313 claims |
| AbbVieSynthroid | $337 | $82320 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $27 | $66771 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,079 family medicine providers in Colorado.
Other family medicine in Castle Rock
- Belton HallmarkCastle Rock$19K
- Aaron BlockCastle Rock$17K
- Ethan LazarusDenver$688K
- Michael de NardisLarkspur$335K
- Matthew YoungColorado Springs$270K
- Mark DeutchmanDenver$258K
- Kari UusinarkausWoodland Park$254K
- Michael MeekerUsaf Academy$174K
- Carolynn Francavilla BrownLakewood$174K
- Lawrence AndrewsColorado Springs$102K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.